EP1157692B1 — Composition of fatty acids containing at least 80% by weight of EPA and DHA or their derivatives and its pharmaceutical use
Assigned to Pro Aparts - Investimentos E Consultoria Lda · Expires 2005-10-05 · 21y expired
What this patent protects
There is described a composition of fatty acids containing at least 80% by weight of acid 5,8,11,14,17-eicosapentaenoic acid (EPA) C20 : 5 omega -3 ( double bonds all cis) and acid 4,7,10,13,16,19-docosaexaenoic acid (DHA) C22:6 omega -3 (double bonds all cis), where the ratio …
USPTO Abstract
There is described a composition of fatty acids containing at least 80% by weight of acid 5,8,11,14,17-eicosapentaenoic acid (EPA) C20 : 5 omega -3 ( double bonds all cis) and acid 4,7,10,13,16,19-docosaexaenoic acid (DHA) C22:6 omega -3 (double bonds all cis), where the ratio EPA:DHA is within 0.9 and 1.5 and other omega -3 acids C20, C21 and C22 constitute less than 3% and where such acids may be present in the form of free acids or their salts or other derivatives pharmaceutically acceptable and a process for the preparation thereof. The compositions of the invention are useful for the production of a pharmaceutical preparation for the treatment and/or prophylaxis of multiple risk factors for cardiovascular diseases and/or other pathologies sensitive to the action of EPA and DHA.
Drugs covered by this patent
- Epanova (OMEGA-3-CARBOXYLIC ACIDS) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.